Current indications for chemotherapy in prostate cancer patients.

@article{Calabr2007CurrentIF,
  title={Current indications for chemotherapy in prostate cancer patients.},
  author={Fabio Calabr{\`o} and Cora N Sternberg},
  journal={European urology},
  year={2007},
  volume={51 1},
  pages={
          17-26
        }
}
Recently, data from two randomized studies, TAX327 and SWOG 9916, which compared docetaxel-based chemotherapy to mitoxantrone-based therapy, have demonstrated that treatment with docetaxel can prolong life in a statistically significant way in patients with hormone refractory prostate cancer (HRPC). In the TAX237 trial the median overall survival rates for patients treated with docetaxel every 3 wk was 18.9 mo, compared with 16.4 mo for the patients in the control arm (p=0.009). Patients… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 49 CITATIONS